Cigna’s Evernorth Expands Digital Health Formulary with Addition of Omada MSK by Physera

Cigna’s Evernorth Expands Digital Health Formulary with Addition of Omada MSK by Physera
Cigna’s Evernorth Expands Digital Health Formulary with Addition of Omada MSK by Physera

What You Should Know:

– Cigna Corporation’s health services segment, Evernorth expands
its digital health formulary with the addition of Omada MSK by Physera.

– Omada MSK by Physera joins Omada’s existing formulary
programs for diabetes prevention, type 2 diabetes, and hypertension.


Cigna Corporation’s health
services segment Evernorth today announced
the expansion of its industry-first Digital Health Formulary,
adding Omada Health’s program for at-home physical therapy and personalized
coaching for chronic pain to the platform. Omada MSK by Physera joins Omada’s
existing formulary programs for diabetes prevention, type 2 diabetes, and
hypertension.


Evernorth Health Services Background

Evernorth provides a distinct and dedicated platform for the
distribution of health solutions geared toward health plans, employers, and
government organizations – inclusive of those without Cigna medical insurance.
This enables Evernorth to partner deeply with, and provide unmatched and
focused support to these groups, all guided by its unwavering commitment to
make health care better. 

To date, health plans covering more than 20 million
Americans offer solutions from Evernorth’s Digital Health Formulary to their
members. Plan sponsors can choose to invest and deploy individual solutions, or
a combination of programs on the platform. In addition to rigorous measurement
from physicians, pharmacists, and health research scientists, programs on the
formulary are also evaluated by user-experience experts. People using programs
on the Digital Health Formulary may also receive support from specialist
pharmacists to further optimize the potential health benefits of the chosen
solutions.


Availability

The musculoskeletal program will be available to formulary
customers beginning in 2021, giving Omada the broadest range of programs on the
industry-leading platform. Created in 2019, the Digital Health Formulary
features solutions that are evaluated and measured on clinical effectiveness,
usability, scalability, and interoperability.


<!–

–>